You are here

Sarel Fleishman

Evolved to Stop Bacteria, Designed for Stability
15.03.2021

New proteins, created through long-distance collaboration, might lead to the reversal of antibiotic resistance in certain bacteria 

Prof. Sarel Fleishman. His research has already led to the design of a potential malaria vaccine, and he is now concentrating his efforts on the coronavirus
19.04.2020

Weizmann Institute scientists have developed a research platform for designing tiny antibodies that can halt the virus infection process

p loops
01.04.2019

Proto-enzymes designed in the lab bound strongly to RNA and DNA, suggesting a surprising origin for these proteins

Medicinal Chemistry
04.12.2018

The Institute will fund innovative research on compounds that hold promise for becoming therapies for a range of human diseases and...

Fleishman and group
01.11.2018

A computational method for designing dramatically more efficient versions of enzymes may lead to new avenues of drug design and new treatments...

Dr. Sarel Fleishman
27.05.2018

Dr. Sarel Fleishman is the recipient of a Morris L. Levinson Prize in Biology awarded by the Scientific Council

Designed and experimental antibody
26.09.2017

Including “non-ideal” components in the designs may be key to functional artificial proteins  

protein repair shop
01.08.2016

A “one-stop,” computer-design “shop” for stabilizing problematic proteins

Dr. Sarel Fleishman
28.03.2016

What is the basic plan for the proteins that connect the inside of a cell to the outside?